Medicinal products for gene therapies
Original notice title
Suministro de medicamentos destinado a terapias genicas mediante SDA
Opportunity Score
Why this score?
Opportunity
60 / 100
Complexity
55 / 100
Risk factors
Selection criteria require annual turnover and references; not meeting thresholds could disqualify.
DPS may have many competitions; each may require separate submission with short deadlines.
Restricted procedure — pre-qualification required
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Overview
Strong opportunityKey Facts
- EUR 65.8M estimated value
- Dynamic Purchasing System (DPS)
- Supplies contract
- 2 lots
- Duration until Apr 2031
- Supply of advanced gene therapy medicinal products for spinal muscular atrophy and hemophilia B.
- Destined for patients of the Canary Health Service (Servicio Canario de la Salud).
Show full summary
This tender is for a Dynamic Purchasing System (DPS) for the supply of advanced gene therapy medicines for spinal muscular atrophy (SMA) and hemophilia B to patients of the Canary Health Service. The DPS is divided into two lots with a total estimated value of €65,765,376. The procedure is restricted, award is based solely on price (100% weight), and submissions are electronic in Spanish. Tenderers may only bid for one lot.
Risks
Selection criteria require annual turnover and references; not meeting thresholds could disqualify.
DPS may have many competitions; each may require separate submission with short deadlines.
Restricted procedure — pre-qualification required
Analysis may be incomplete
Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.
Key Requirements
Administrative
- Restricted procedure: only invited candidates may submit tenders.
- Electronic submission is required.
- All documents must be in Spanish.
Requirements may be incomplete.
Award Criteria
Lot 1
Lot 2
Buyer
Name
Dirección General de Recursos Económicos del Servicio Canario de la Salud
Location
Las Palmas de Gran Canaria, ESP
Buyer profile
Identifier
21058580149618
Lots (2)
LOT-0001
Terapia génica para la atrofia muscular espinal
Supply of gene therapy for spinal muscular atrophy (SMA).
EUR 24.7M
Estimated value
Location
Category
Award details
Value note
Show original TED data
Original TED description
Terapia génica para la atrofia muscular espinal
LOT-0002
Terapia génica para la hemofilia B
Supply of gene therapy for hemophilia B.
EUR 30.1M
Estimated value
Location
Category
Value note
Procurement Details
- Publication date
- 19 Apr 2026
- Notice type
- Contract notice — standard
- Languages
- Spanish
Reference metadata
- Notice subtype
- 16
- Notice version
- 1
- Legal basis
- 32014L0024
Reference IDs
- Tender ID
- 267052-2026
- Source notice ID
- 1fb71b04-28e1-4636-be93-e2a45cf847d0
Documents (1)
Similar tenders
Spain – Disposable non-chemical medical consumables and haematological consumables – Contrato Acuerdo Marco de Suministro (CONTR 2026 0000208879)
Spain – Buses and coaches – Contratación mixta del suministro mediante renting de un autobús urbano diese, así como el servicio de un taller mecánico para el mantenimiento preventivo y correctivo.
Spain – Angiography devices – Renovación tecnológica del equipo Artis Zeego instalado en el Hospital Universitario Central de Asturias
Spain – Disposable gloves – Acuerdo Marco para el suministro respetuoso con el medio ambiente de guantes con destino a los centros del ámbito de la sanidad pública valenciana
Spain – Miscellaneous software package and computer systems – Suministro de licencia de Máximo Application Suite (MAS) en movilidad de SaaS Gestionado por IBM para la Empresa Municipal de Transportes de València S.A.U (Medio Propio)
Spain – Surgical implants – Contrato Acuerdo Marco de Suministro (CONTR 2026 0000216568)
Opportunity Score
Why this score?
Opportunity
60 / 100
Complexity
55 / 100
Risk factors
Selection criteria require annual turnover and references; not meeting thresholds could disqualify.
DPS may have many competitions; each may require separate submission with short deadlines.
Restricted procedure — pre-qualification required
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications